Tag:
Baxter
Latest Headlines
Latest Headlines
CMO service pacts needed for success, Baxter says
Before Big Pharma and biotech companies start working with CMOs, they should also formulate service agreements, as Raul Soikes, senior director of program management in R&D at Baxter International, recommended at Interphex this year.
UPDATED: Baxter bitten again by problems with Colleague infusion pumps
The company says it was served a subpoena in March by the SEC which wants info "related to the company's accounting treatment, financial reporting and disclosures relating to the remediation and recall of the company's Colleague and Syndeo infusion pumps," MassDevice reports.
Baxter beats Wall Street projections but gets FDA questions on new treatment
The company reported improved earnings but also learned the FDA wants more data on the immune deficiency drug it is developing.
Baxter to erect $1B plasma plant
The company said construction will begin this year, and the facility is slated to be operational in 2018.
FDA says APP ignored consumer complaints for 18 months
New details about problems with the production of heparin and other drugs by APP Pharmaceuticals ( $APPX ) have been released by the Food and Drug Administration on its website.
FDA triples list of banned Chinese heparin ingredient makers
Facing an ongoing House investigation over the tainted heparin episode, the FDA has identified another 14 Chinese companies that supplied contaminated materials to drugmakers. This brings to 22 the...
Merck leads 2011's list of job-cutting drugmakers
Perhaps the most persistent trend in the drug business is one management would prefer to discuss only with analysts, and certainly not with the rank-and-file. Once again, a laundry list of pharma
Pfizer near agreement to resolve bribery probe
The U.S. government's Foreign Corrupt Practices Act crackdown rolls on, with Pfizer ( $PFE ) becoming the latest drugmaker to reach a tentative deal. The company disclosed that it's close to a final
UPDATED:Drugmakers respond to shortages order, HHS report
Generic drugmakers have pledged to work with the FDA to formalize the process for manufacturers and other members of the supply chain to report drug shortages to the FDA, "as many now do
Ranking: Baxter, J&J lead green pharma companies
Baxter ( $BAX ) leads public-company drugmakers in Newsweek's annual top 500 global sustainability ratings. Finishing in the 24th spot, it edged out Johnson & Johnson ( $JNJ ) in 26th place and
